A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

NCT00002162 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Saquinavir
DRUG: Lamivudine
DRUG: Stavudine
DRUG: Zidovudine
DRUG: Zalcitabine
DRUG: Didanosine

Sponsor

Hoffmann-La Roche